Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

AstraZeneca Total Assets 2010-2025 | AZN

AstraZeneca total assets from 2010 to 2025. Total assets can be defined as the sum of all assets on a company's balance sheet.
  • AstraZeneca total assets for the quarter ending March 31, 2025 were $106.253B, a 3.87% increase year-over-year.
  • AstraZeneca total assets for 2024 were $104.035B, a 2.88% increase from 2023.
  • AstraZeneca total assets for 2023 were $101.119B, a 4.8% increase from 2022.
  • AstraZeneca total assets for 2022 were $96.483B, a 8.43% decline from 2021.
  
AstraZeneca Annual Total Assets
(Millions of US $)
2024 $104,035
2023 $101,119
2022 $96,483
2021 $105,363
2020 $66,729
2019 $61,377
2018 $60,651
2017 $63,354
2016 $62,526
2015 $60,056
2014 $58,595
2013 $55,899
2012 $53,534
2011 $52,830
2010 $56,127
2009 $54,920
AstraZeneca Quarterly Total Assets
(Millions of US $)
2025-03-31 $106,253
2024-12-31 $104,035
2024-09-30 $104,922
2024-06-30 $104,340
2024-03-31 $102,293
2023-12-31 $101,119
2023-09-30 $96,086
2023-06-30 $96,543
2023-03-31 $96,687
2022-12-31 $96,483
2022-09-30 $94,185
2022-06-30 $96,579
2022-03-31 $100,273
2021-12-31 $105,363
2021-09-30 $107,221
2021-06-30 $73,641
2021-03-31 $64,926
2020-12-31 $66,729
2020-09-30 $64,112
2020-06-30 $59,929
2020-03-31 $57,211
2019-12-31 $61,377
2019-09-30 $58,906
2019-06-30 $61,889
2019-03-31 $61,055
2018-12-31 $60,651
2018-09-30 $61,443
2018-06-30 $61,344
2018-03-31 $63,281
2017-12-31 $63,354
2017-09-30 $64,587
2017-06-30 $65,119
2017-03-31 $60,959
2016-12-31 $62,526
2016-09-30 $63,222
2016-06-30 $64,419
2016-03-31 $64,323
2015-12-31 $60,056
2015-09-30 $54,118
2015-06-30 $55,169
2015-03-31 $53,701
2014-12-31 $58,595
2014-09-30 $56,164
2014-06-30 $58,539
2014-03-31 $59,390
2013-12-31 $55,899
2013-09-30 $54,121
2013-06-30 $53,987
2013-03-31 $52,329
2012-12-31 $53,534
2012-09-30 $52,448
2012-06-30 $51,390
2012-03-31 $50,763
2011-12-31 $52,830
2011-09-30 $52,576
2011-06-30 $53,406
2011-03-31 $54,534
2010-12-31 $56,127
2010-09-30 $56,390
2010-06-30 $54,647
2010-03-31 $54,075
2009-12-31 $54,920
2009-09-30 $51,899
2009-06-30 $50,200
2009-03-31 $46,515
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $213.340B $54.073B
AstraZeneca plc, is one of the largest biopharmaceutical companies in the world. AstraZeneca's business can be broken down into separate lines based on therapeutic classes. These include cardiovascular, respiratory, immunology, oncology, rare diseases and other.In July 2021 AstraZeneca closed the acquisition of rare disease drugmaker, Alexion. The acquisition added Alexion's five marketed rare disease products and its pipeline of immune-mediated rare disease candidates.In order to bolster its respiratory portfolio, AstraZeneca acquired rights to Allergan's branded respiratory business in the U.S. and Canada in Mar 2015. The company also acquired Takeda's core respiratory business in May 2016.In June 2007, AstraZeneca acquired biotechnology company MedImmune. In Aug 2011, AstraZeneca sold its Astra Tech business to DENTSPLY. AstraZeneca entered into a number of deals and struck agreements with companies such as FibroGen and Daiichi Sankyo.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $158.494B 14.20
Gilead Sciences (GILD) United States $134.618B 13.98
Vertex Pharmaceuticals (VRTX) United States $118.078B 0.00
Bristol Myers Squibb (BMY) United States $96.381B 6.45
CSL (CSLLY) Australia $81.173B 0.00
GSK (GSK) United Kingdom $74.339B 8.90
Regeneron Pharmaceuticals (REGN) United States $58.573B 14.22
Alnylam Pharmaceuticals (ALNY) United States $41.793B 0.00
Argenex SE (ARGX) Netherlands $34.553B 94.10
BioNTech SE (BNTX) Germany $26.448B 0.00
Royalty Pharma (RPRX) United States $20.010B 8.45
Insmed (INSM) United States $19.456B 0.00
Biogen (BIIB) United States $18.315B 7.90
Illumina (ILMN) United States $15.219B 28.87
Genmab (GNMSF) Denmark $14.299B 14.62
Genmab (GMAB) Denmark $14.037B 15.74
Incyte (INCY) United States $13.136B 99.79
Exelixis (EXEL) United States $12.127B 20.59
Moderna (MRNA) United States $12.090B 0.00
BioMarin Pharmaceutical (BMRN) United States $10.987B 17.85
QIAGEN (QGEN) Netherlands $10.750B 20.92
Swedish Orphan Biovitrum (BIOVF) Sweden $10.605B 23.46
Ascendis Pharma (ASND) Denmark $10.386B 0.00
Exact Sciences (EXAS) United States $9.519B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $8.930B 0.00
Bio-Techne Corp (TECH) United States $8.155B 30.42
Roivant Sciences (ROIV) United Kingdom $7.777B 0.00
Legend Biotech (LEGN) United States $7.643B 0.00
Revolution Medicines (RVMD) United States $7.134B 0.00
Bio-Rad Laboratories (BIO.B) United States $7.014B 24.41
Halozyme Therapeutics (HALO) United States $6.956B 13.31
Jazz Pharmaceuticals (JAZZ) Ireland $6.830B 6.71
Anbio Biotechnology (NNNN) Germany $6.761B 0.00
Repligen (RGEN) United States $6.531B 73.11
TG Therapeutics (TGTX) United States $6.018B 157.96
Nuvalent (NUVL) United States $5.989B 0.00
Guardant Health (GH) United States $5.756B 0.00
Rhythm Pharmaceuticals (RYTM) United States $5.675B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.625B 0.00
Axsome Therapeutics (AXSM) United States $5.500B 0.00
Telix Pharmaceuticals (TLX) Australia $5.492B 0.00
Alkermes (ALKS) Ireland $4.818B 12.93
Vaxcyte (PCVX) United States $4.671B 0.00
Metsera (MTSR) United States $4.487B 0.00
Cytokinetics (CYTK) United States $4.446B 0.00
Merus (MRUS) Netherlands $4.378B 0.00
Krystal Biotech (KRYS) United States $4.262B 32.85
Akero Therapeutics (AKRO) United States $4.152B 0.00
Avidity Biosciences (RNA) United States $4.069B 0.00
ADMA Biologics Inc (ADMA) United States $3.994B 29.88
Zealand Pharma (ZLDPF) Denmark $3.965B 0.00
Scholar Rock Holding (SRRK) United States $3.866B 0.00
ACADIA Pharmaceuticals (ACAD) United States $3.776B 33.18
PTC Therapeutics (PTCT) United States $3.775B 6.57
Zai Lab (ZLAB) China $3.729B 0.00
Arcellx (ACLX) United States $3.725B 0.00
Viking Therapeutics (VKTX) United States $3.595B 0.00
Ascentage Pharma Group - (AAPG) China $3.519B 0.00
Protagonist Therapeutics (PTGX) United States $3.439B 73.97
MoonLake Immunotherapeutics (MLTX) Switzerland $3.398B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.068B 0.00
Immunovant (IMVT) United States $3.064B 0.00
Kymera Therapeutics (KYMR) United States $3.007B 0.00
Ligand Pharmaceuticals (LGND) United States $2.684B 0.00
Alvotech (ALVO) Luxembourg $2.602B 14.88
Mirum Pharmaceuticals (MIRM) United States $2.572B 0.00
Ultragenyx Pharmaceutical (RARE) United States $2.487B 0.00
Apellis Pharmaceuticals (APLS) United States $2.447B 0.00
ImmunityBio (IBRX) United States $2.427B 0.00
Xenon Pharmaceuticals (XENE) Canada $2.424B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.374B 0.00
Agios Pharmaceuticals (AGIO) United States $2.317B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $2.315B 0.00
Bavarian Nordic (BVNRY) Denmark $2.250B 11.89
Kiniksa Pharmaceuticals (KNSA) United Kingdom $2.118B 0.00
Twist Bioscience (TWST) United States $2.107B 0.00
Beam Therapeutics (BEAM) United States $2.087B 0.00
CG Oncology (CGON) United States $2.039B 0.00
Denali Therapeutics (DNLI) United States $2.034B 0.00
Harmony Biosciences Holdings (HRMY) United States $2.021B 13.44
Disc Medicine (IRON) United States $2.001B 0.00
Mesoblast (MESO) Australia $1.996B 0.00
Belite Bio (BLTE) United States $1.940B 0.00
IDEAYA Biosciences (IDYA) United States $1.891B 0.00
Amicus Therapeutics (FOLD) United States $1.835B 198.67
Immunocore Holdings (IMCR) United Kingdom $1.824B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.817B 0.00
Apogee Therapeutics (APGE) United States $1.810B 0.00
NovoCure (NVCR) Jersey $1.786B 0.00
Vericel (VCEL) United States $1.779B 1178.00
Arcutis Biotherapeutics (ARQT) United States $1.749B 0.00
Certara (CERT) United States $1.639B 30.61
Adaptive Biotechnologies (ADPT) United States $1.578B 0.00
Janux Therapeutics (JANX) United States $1.562B 0.00
89BIO (ETNB) United States $1.531B 0.00
Celldex Therapeutics (CLDX) United States $1.488B 0.00
Vera Therapeutics (VERA) United States $1.470B 0.00
ANI Pharmaceuticals (ANIP) United States $1.436B 14.80
Biohaven (BHVN) United States $1.435B 0.00
Travere Therapeutics (TVTX) United States $1.431B 0.00
Edgewise Therapeutics (EWTX) United States $1.424B 0.00
Cogent Biosciences (COGT) United States $1.422B 0.00
Sarepta Therapeutics (SRPT) United States $1.383B 0.00
Viridian Therapeutics (VRDN) United States $1.348B 0.00
AbCellera Biologics (ABCL) Canada $1.337B 0.00
WAVE Life Sciences (WVE) Singapore $1.297B 0.00
Dynavax Technologies (DVAX) United States $1.287B 76.57
GRAIL (GRAL) United States $1.266B 0.00
Intellia Therapeutics (NTLA) United States $1.249B 0.00
Liquidia Technologies (LQDA) United States $1.243B 0.00
Pharvaris (PHVS) Netherlands $1.215B 0.00
CureVac (CVAC) Germany $1.209B 5.86
Cidara Therapeutics (CDTX) United States $1.209B 0.00
MannKind (MNKD) United States $1.143B 23.50
Novavax (NVAX) United States $1.134B 2.64
Structure Therapeutics (GPCR) United States $1.104B 0.00
BGM Group (BGM) China $1.098B 0.00
Praxis Precision Medicines (PRAX) United States $1.097B 0.00
Sana Biotechnology (SANA) United States $1.044B 0.00
Pacira BioSciences (PCRX) United States $0.999B 9.51
Zymeworks (ZYME) United States $0.993B 0.00
Spyre Therapeutics (SYRE) United States $0.982B 0.00
Arcus Biosciences (RCUS) United States $0.969B 0.00
LENZ Therapeutics (LENZ) United States $0.949B 0.00
MiMedx (MDXG) United States $0.948B 22.93
Oric Pharmaceuticals (ORIC) United States $0.938B 0.00
Anavex Life Sciences (AVXL) United States $0.938B 0.00
Replimune (REPL) United States $0.932B 0.00
Mineralys Therapeutics (MLYS) United States $0.927B 0.00
Immunome (IMNM) United States $0.921B 0.00
GH Research (GHRS) Ireland $0.914B 0.00
Nurix Therapeutics (NRIX) United States $0.857B 0.00
UniQure (QURE) Netherlands $0.821B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.814B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.808B 0.00
Trevi Therapeutics (TRVI) United States $0.805B 0.00
NeoGenomics (NEO) United States $0.803B 0.00
Jyong Biotech (MENS) Taiwan $0.802B 0.00
Niagen Bioscience (NAGE) United States $0.801B 112.94
Geron (GERN) United States $0.790B 0.00
Nuvation Bio (NUVB) United States $0.783B 0.00
Maze Therapeutics (MAZE) United States $0.779B 0.00
Pharming Group (PHGUF) Netherlands $0.772B 0.00
Oculis Holding AG (OCS) Switzerland $0.764B 0.00
AnaptysBio (ANAB) United States $0.762B 0.00
ArriVent BioPharma (AVBP) United States $0.754B 0.00
Vir Biotechnology (VIR) United States $0.748B 0.00
Iovance Biotherapeutics (IOVA) United States $0.745B 0.00
Sionna Therapeutics (SION) United States $0.739B 0.00
CorMedix Inc (CRMD) United States $0.737B 49.36
Tango Therapeutics (TNGX) United States $0.734B 0.00
Immatics (IMTX) Germany $0.729B 0.00
Stoke Therapeutics (STOK) United States $0.722B 16.73
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.717B 0.00
Urogen Pharma (URGN) United States $0.705B 0.00
Pharming Group (PHAR) Netherlands $0.703B 0.00
MeiraGTx Holdings (MGTX) United States $0.693B 0.00
Gyre Therapeutics (GYRE) United States $0.676B 180.25
Mind Medicine (MindMed) (MNMD) United States $0.671B 0.00
Dianthus Therapeutics (DNTH) United States $0.656B 0.00
Day One Biopharmaceuticals (DAWN) United States $0.649B 0.00
Sinovac Biotech (SVA) China $0.645B 0.00
Autolus Therapeutics (AUTL) United Kingdom $0.641B 0.00
Abivax SA (ABVX) France $0.632B 0.00
Arbutus Biopharma (ABUS) United States $0.599B 0.00
Bicara Therapeutics (BCAX) United States $0.596B 0.00
Ginkgo Bioworks Holdings (DNA) United States $0.593B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.593B 0.00
Upstream Bio (UPB) United States $0.577B 0.00
Zenas BioPharma (ZBIO) United States $0.574B 0.00
Sage Therapeutics (SAGE) United States $0.570B 0.00
Septerna (SEPN) United States $0.559B 0.00
Keros Therapeutics (KROS) United States $0.558B 0.00
Prime Medicine (PRME) United States $0.555B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.555B 0.00
Tyra Biosciences (TYRA) United States $0.552B 0.00
Kura Oncology (KURA) United States $0.551B 0.00
Arvinas (ARVN) United States $0.536B 0.00
Rapport Therapeutics (RAPP) United States $0.536B 0.00
ATyr Pharma (ATYR) United States $0.533B 0.00
Oxford BioMedica (OXBDF) United Kingdom $0.530B 0.00
Opthea (OPT) Australia $0.525B 0.00
Precigen (PGEN) United States $0.520B 0.00
Celcuity (CELC) United States $0.515B 0.00
Solid Biosciences (SLDB) United States $0.495B 0.00
Terns Pharmaceuticals (TERN) United States $0.493B 0.00
Castle Biosciences (CSTL) United States $0.478B 32.43
PureTech Health (PRTC) United States $0.473B 0.00
Rezolute (RZLT) United States $0.461B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.445B 0.00
Cullinan Therapeutics (CGEM) United States $0.444B 0.00
Kamada (KMDA) Israel $0.428B 25.69
Erasca (ERAS) United States $0.425B 0.00
Fortrea Holdings (FTRE) United States $0.424B 11.73
Compass Therapeutics (CMPX) United States $0.415B 0.00
Fulcrum Therapeutics (FULC) United States $0.413B 0.00
Myriad Genetics (MYGN) United States $0.412B 0.00
REGENXBIO (RGNX) United States $0.409B 0.00
Tectonic Therapeutic (TECX) United States $0.409B 0.00
Eton Pharmaceuticals (ETON) United States $0.403B 0.00
Absci (ABSI) United States $0.398B 0.00
Cytek Biosciences (CTKB) United States $0.396B 0.00
MBX Biosciences (MBX) United States $0.393B 0.00
ITeos Therapeutics (ITOS) United States $0.393B 0.00
Northwest Biotherapeutics (NWBO) United States $0.387B 0.00
Gossamer Bio (GOSS) United States $0.386B 0.00
Vigil Neuroscience (VIGL) United States $0.385B 0.00
Emergent Biosolutions (EBS) United States $0.376B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.366B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.365B 74.25
Humacyte (HUMA) United States $0.361B 0.00
Inhibrx Biosciences (INBX) United States $0.354B 0.21
Foghorn Therapeutics (FHTX) United States $0.342B 0.00
Candel Therapeutics (CADL) United States $0.338B 0.00
Aura Biosciences (AURA) United States $0.337B 0.00
Abeona Therapeutics (ABEO) United States $0.337B 0.00
Prothena (PRTA) Ireland $0.337B 0.00
Astria Therapeutics (ATXS) United States $0.337B 0.00
Amarin (AMRN) Ireland $0.328B 0.00
Palvella Therapeutics (PVLA) United States $0.326B 0.00
Rocket Pharmaceuticals (RCKT) United States $0.325B 0.00
Inventiva S.A (IVA) France $0.324B 0.00
Neurogene (NGNE) United States $0.319B 0.00
Cartesian Therapeutics (RNAC) United States $0.307B 0.00
XOMA Royalty (XOMA) United States $0.307B 0.00
Olema Pharmaceuticals (OLMA) United States $0.302B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.301B 0.00
Neumora Therapeutics (NMRA) United States $0.299B 0.00
Ocugen (OCGN) United States $0.298B 0.00
Kodiak Sciences (KOD) United States $0.291B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.291B 0.00
Benitec Biopharma (BNTC) United States $0.290B 0.00
Sagimet Biosciences (SGMT) United States $0.289B 0.00
Atea Pharmaceuticals (AVIR) United States $0.288B 0.00
Cardiff Oncology (CRDF) United States $0.285B 0.00
Monopar Therapeutics (MNPR) United States $0.284B 0.00
Verastem (VSTM) United States $0.284B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.282B 0.00
Mereo BioPharma Group - (MREO) United Kingdom $0.281B 0.00
Lifecore Biomedical (LFCR) United States $0.277B 0.00
Vor Biopharma (VOR) $0.276B 0.00
DBV Technologies S.A (DBVT) France $0.274B 0.00
Allogene Therapeutics (ALLO) United States $0.273B 0.00
Zhengye Biotechnology Holding (ZYBT) China $0.268B 0.00
Crescent Biopharma (CBIO) United States $0.261B 0.00
ScPharmaceuticals (SCPH) United States $0.261B 0.00
Annexon (ANNX) United States $0.255B 0.00
Aardvark Therapeutics (AARD) United States $0.252B 0.00
Prima BioMed (IMMP) Australia $0.248B 0.00
Third Harmonic Bio (THRD) United States $0.246B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.238B 0.00
Entrada Therapeutics (TRDA) United States $0.238B 7.73
Codexis (CDXS) United States $0.234B 0.00
Adherex Technologies (FENC) United States $0.233B 0.00
Editas Medicine (EDIT) United States $0.231B 0.00
Tvardi Therapeutics (TVRD) United States $0.230B 0.00
Alpha Teknova (TKNO) United States $0.228B 0.00
Semper Paratus Acquisition (TVGN) United States $0.226B 0.00
Design Therapeutics (DSGN) United States $0.226B 0.00
Ventyx Biosciences (VTYX) United States $0.225B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.222B 0.00
Adocia (ADOCY) France $0.216B 0.00
MaxCyte (MXCT) United States $0.215B 0.00
CARGO Therapeutics (CRGX) United States $0.211B 0.00
AC Immune (ACIU) Switzerland $0.208B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.195B 0.00
EnGene Holdings (ENGN) Canada $0.194B 0.00
Rapt Therapeutics (RAPT) United States $0.193B 0.00
CytomX Therapeutics (CTMX) United States $0.192B 4.97
Caribou Biosciences (CRBU) United States $0.191B 0.00
Eupraxia Pharmaceuticals (EPRX) Canada $0.190B 0.00
GENFIT S.A (GNFT) France $0.190B 0.00
BioStem Technologies (BSEM) $0.188B 7.65
Bright Minds Biosciences (DRUG) United States $0.184B 0.00
Alumis (ALMS) United States $0.181B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.181B 0.00
Voyager Therapeutics (VYGR) United States $0.179B 0.00
DiaMedica Therapeutics (DMAC) United States $0.179B 0.00
Black Diamond Therapeutics (BDTX) United States $0.178B 52.17
Innate Pharma S.A (IPHA) France $0.177B 0.00
SELLAS Life Sciences (SLS) United States $0.177B 0.00
I-Mab (IMAB) United States $0.171B 0.00
Instil Bio (TIL) United States $0.171B 0.00
Puma Biotechnology (PBYI) United States $0.169B 4.42
Agenus (AGEN) United States $0.169B 0.00
Kyverna Therapeutics (KYTX) United States $0.169B 0.00
BioAge Labs (BIOA) United States $0.166B 0.00
C4 Therapeutics (CCCC) United States $0.165B 0.00
Nuvectis Pharma (NVCT) United States $0.163B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.161B 0.00
Alpha Cognition (ACOG) Canada $0.160B 0.00
Alector (ALEC) United States $0.159B 0.00
Cuprina Holdings (Cayman) (CUPR) Singapore $0.159B 0.00
Greenwich LifeSciences (GLSI) United States $0.155B 0.00
Anika Therapeutics (ANIK) United States $0.151B 0.00
Elicio Therapeutics (ELTX) United States $0.149B 0.00
Immuneering (IMRX) United States $0.149B 0.00
Molecular Partners AG (MOLN) Switzerland $0.145B 0.00
Theratechnologies (THTX) Canada $0.144B 0.00
Tenaya Therapeutics (TNYA) United States $0.143B 0.00
Compugen (CGEN) Israel $0.137B 0.00
Nkarta (NKTX) United States $0.136B 0.00
IO Biotech (IOBT) Denmark $0.135B 0.00
23andMe Holding (MEHCQ) United States $0.135B 0.00
Spero Therapeutics (SPRO) United States $0.133B 0.00
Zura Bio (ZURA) United States $0.131B 0.00
Fate Therapeutics (FATE) United States $0.130B 0.00
Genelux (GNLX) United States $0.126B 0.00
Seer (SEER) United States $0.124B 0.00
Seres Therapeutics (MCRB) United States $0.123B 0.00
Skye Bioscience (SKYE) United States $0.120B 0.00
Oncolytics Biotech (ONCY) Canada $0.120B 0.00
Sangamo Therapeutics (SGMO) United States $0.119B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.118B 0.00
TuHURA Biosciences (HURA) United States $0.114B 0.00
BioHarvest Sciences (BHST) Canada $0.114B 0.00
Actuate Therapeutics (ACTU) United States $0.113B 0.00
Contineum Therapeutics (CTNM) United States $0.113B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.111B 0.00
Citius Oncology (CTOR) United States $0.109B 0.00
HilleVax (HLVX) United States $0.103B 0.00
TScan Therapeutics (TCRX) United States $0.103B 0.00
Coherus Oncology (CHRS) United States $0.102B 0.00
Climb Bio (CLYM) United States $0.102B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.101B 0.00
OKYO Pharma (OKYO) $0.101B 0.00
Cellectis S.A (CLLS) France $0.101B 0.00
Coya Therapeutics (COYA) United States $0.097B 0.00
Prenetics Global (PRE) Hong Kong, SAR China $0.097B 0.00
Connect Biopharma Holdings (CNTB) United States $0.096B 0.00
Entera Bio (ENTX) Israel $0.093B 0.00
Immunic (IMUX) United States $0.092B 0.00
Nautilus Biotechnology (NAUT) United States $0.091B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.091B 0.00
XBiotech (XBIT) United States $0.091B 0.00
Invivyd (IVVD) United States $0.090B 0.00
BeyondSpring (BYSI) United States $0.088B 0.00
Pliant Therapeutics (PLRX) United States $0.088B 0.00
Elutia (ELUT) United States $0.087B 0.00
Quince Therapeutics (QNCX) United States $0.086B 0.00
Whitehawk Therapeutics (WHWK) United States $0.085B 0.00
Cabaletta Bio (CABA) United States $0.085B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.084B 0.00
TELA Bio (TELA) United States $0.084B 0.00
Immix Biopharma (IMMX) United States $0.083B 0.00
Adagene (ADAG) China $0.082B 0.00
MiNK Therapeutics (INKT) United States $0.081B 0.00
EXoZymes (EXOZ) United States $0.077B 0.00
IGM Biosciences (IGMS) United States $0.077B 0.00
Alto Neuroscience (ANRO) United States $0.075B 0.00
VistaGen Therapeutics (VTGN) United States $0.074B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.074B 0.00
Oncobiologics (OTLK) United States $0.073B 0.00
Celularity (CELU) United States $0.073B 0.00
Biomea Fusion (BMEA) United States $0.070B 0.00
Genenta Science S.p.A (GNTA) Italy $0.069B 0.00
Quantum Biopharma (QNTM) Canada $0.068B 0.00
Cue Biopharma (CUE) United States $0.068B 0.00
Opus Genetics (IRD) United States $0.067B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.067B 0.00
Forte Biosciences (FBRX) United States $0.067B 0.00
Applied Therapeutics (APLT) United States $0.065B 0.00
Repare Therapeutics (RPTX) Canada $0.065B 0.00
CervoMed (CRVO) United States $0.064B 0.00
Sutro Biopharma (STRO) United States $0.064B 0.00
Werewolf Therapeutics (HOWL) United States $0.063B 0.00
Adicet Bio (ACET) United States $0.063B 0.00
Scilex Holding (SCLX) United States $0.062B 0.00
Ikena Oncology (IKNA) United States $0.061B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.060B 0.00
MediciNova (MNOV) United States $0.060B 0.00
Atara Biotherapeutics (ATRA) United States $0.060B 0.00
Artiva Biotherapeutics (ARTV) United States $0.058B 0.00
InflaRx (IFRX) Germany $0.058B 0.00
Adverum Biotechnologies (ADVM) United States $0.058B 0.00
Fortress Biotech (FBIO) United States $0.058B 0.00
INmune Bio (INMB) United States $0.057B 0.00
ABVC BioPharma (ABVC) United States $0.057B 0.00
Aligos Therapeutics (ALGS) United States $0.056B 0.00
Adlai Nortye (ANL) Cayman Islands $0.055B 0.00
Renovaro (RENB) United States $0.055B 0.00
VTv Therapeutics (VTVT) United States $0.054B 0.00
Earth Science Tech (ETST) United States $0.053B 0.00
PDS Biotechnology (PDSB) United States $0.053B 0.00
Annovis Bio (ANVS) United States $0.052B 0.00
Precision BioSciences (DTIL) United States $0.051B 0.00
Inovio Pharmaceuticals (INO) United States $0.051B 0.00
Senti Biosciences (SNTI) United States $0.051B 0.00
ZIVO Bioscience (ZIVO) United States $0.051B 0.00
Exicure (XCUR) United States $0.050B 0.00
Jasper Therapeutics (JSPR) United States $0.050B 0.00
RenovoRx (RNXT) United States $0.048B 0.00
Grace Therapeutics (GRCE) Canada $0.046B 0.00
Kalaris Therapeutics (KLRS) United States $0.045B 0.00
Alterity Therapeutics - (ATHE) Australia $0.044B 0.00
PepGen (PEPG) United States $0.044B 0.00
Mersana Therapeutics (MRSN) United States $0.044B 0.00
Lantern Pharma (LTRN) United States $0.043B 0.00
Medicus Pharma (MDCX) United States $0.042B 0.00
CalciMedica (CALC) United States $0.042B 0.00
Pluri (PLUR) Israel $0.041B 0.00
Cognition Therapeutics (CGTX) United States $0.041B 0.00
Ovid Therapeutics (OVID) United States $0.039B 0.00
Shattuck Labs (STTK) United States $0.039B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.038B 0.00
Xilio Therapeutics (XLO) United States $0.037B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.037B 0.00
KALA BIO (KALA) United States $0.037B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.036B 0.00
Radiopharm Theranostics - (RADX) Australia $0.035B 0.00
AN2 Therapeutics (ANTX) United States $0.033B 0.00
CAMP4 Therapeutics (CAMP) United States $0.032B 0.00
Clearside Biomedical (CLSD) United States $0.032B 0.00
Kezar Life Sciences (KZR) United States $0.032B 0.00
Clene (CLNN) United States $0.032B 0.00
OnKure Therapeutics (OKUR) United States $0.031B 0.00
Rein Therapeutics (RNTX) United States $0.031B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.031B 0.00
Estrella Immunopharma (ESLA) United States $0.031B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.030B 0.00
Dyadic (DYAI) United States $0.029B 0.00
Femasys (FEMY) United States $0.029B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.028B 0.00
Generation Bio (GBIO) United States $0.027B 0.00
Boundless Bio (BOLD) United States $0.027B 0.00
ALX Oncology Holdings (ALXO) United States $0.027B 0.00
Q32 Bio (QTTB) United States $0.027B 0.00
FibroBiologics (FBLG) United States $0.027B 0.00
Rani Therapeutics Holdings (RANI) United States $0.026B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.026B 0.00
Tenax Therapeutics (TENX) United States $0.025B 0.00
Moleculin Biotech (MBRX) United States $0.024B 0.00
SAB Biotherapeutics (SABS) United States $0.024B 0.00
Longeveron (LGVN) United States $0.023B 0.00
Dare Bioscience (DARE) United States $0.022B 0.00
Elevation Oncology (ELEV) United States $0.022B 0.00
Cadrenal Therapeutics (CVKD) United States $0.022B 0.00
Cingulate (CING) United States $0.022B 0.00
Lisata Therapeutics (LSTA) United States $0.022B 0.00
Chemomab Therapeutics (CMMB) Israel $0.021B 0.00
Aytu BioPharma (AYTU) United States $0.021B 0.00
Cyclacel Pharmaceuticals (CYCC) $0.021B 0.00
BioAtla (BCAB) United States $0.021B 0.00
Synlogic (SYBX) United States $0.020B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.020B 0.00
Curis (CRIS) United States $0.019B 0.00
Lexaria Bioscience (LEXX) Canada $0.018B 0.00
Rallybio (RLYB) United States $0.018B 0.00
Aspire Biopharma Holdings (ASBP) United States $0.018B 0.00
Passage Bio (PASG) United States $0.017B 0.00
Gelteq (GELS) Australia $0.017B 0.00
Edesa Biotech (EDSA) Canada $0.017B 0.00
Hoth Therapeutics (HOTH) United States $0.017B 0.00
Athira Pharma (ATHA) United States $0.016B 0.00
Allarity Therapeutics (ALLR) United States $0.015B 0.00
Advanced Biomed (ADVB) United States $0.015B 0.00
Equillium (EQ) United States $0.015B 0.00
Promis Neurosciences (PMN) Canada $0.014B 0.00
Leap Therapeutics (LPTX) United States $0.014B 0.00
Beyond Air (XAIR) United States $0.014B 0.00
Synaptogenix (TAOX) United States $0.014B 0.00
Neuphoria Therapeutics (NEUP) Australia $0.014B 0.00
HOOKIPA Pharma (HOOK) United States $0.014B 0.00
COSCIENS Biopharma (CSCI) Canada $0.014B 0.00
NextCure (NXTC) United States $0.013B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.013B 0.00
MetaVia (MTVA) United States $0.013B 0.00
Abpro Holdings (ABP) United States $0.012B 0.00
BioCardia (BCDA) United States $0.012B 0.00
GeoVax Labs (GOVX) United States $0.012B 0.00
IBio (IBIO) United States $0.012B 0.00
Biorestorative Therapies (BRTX) United States $0.012B 0.00
BioXcel Therapeutics (BTAI) United States $0.012B 0.00
Bionano Genomics (BNGO) United States $0.012B 0.00
Cyclerion Therapeutics (CYCN) United States $0.011B 0.00
180 Life Sciences (ATNF) United States $0.011B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.011B 0.00
Bolt Biotherapeutics (BOLT) United States $0.011B 0.00
Novogen (KZIA) Australia $0.010B 0.00
BioAffinity Technologies (BIAF) United States $0.010B 0.00
IMMURON (IMRN) Australia $0.010B 0.00
Sensei Biotherapeutics (SNSE) United States $0.010B 0.00
Imunon (IMNN) United States $0.010B 0.00
Mustang Bio (MBIO) United States $0.010B 0.00
Dogwood Therapeutics (DWTX) United States $0.009B 0.00
Aprea Therapeutics (APRE) United States $0.009B 0.00
GENPREX (GNPX) United States $0.009B 0.00
Turnstone Biologics (TSBX) United States $0.008B 0.00
Biofrontera (BFRI) United States $0.008B 0.00
X4 Pharmaceuticals (XFOR) United States $0.008B 0.00
Artelo Biosciences (ARTL) United States $0.008B 0.00
Intensity Therapeutics (INTS) United States $0.008B 0.00
Jade Biosciences (JBIO) United States $0.008B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.007B 0.00
Silexion Therapeutics Corp (SLXN) Israel $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Sunshine Biopharma (SBFM) United States $0.007B 0.00
Evogene (EVGN) Israel $0.007B 0.00
Apollomics (APLM) United States $0.007B 0.00
GT Biopharma (GTBP) United States $0.007B 0.00
Purple Biotech (PPBT) Israel $0.007B 0.00
IN8bio (INAB) United States $0.007B 0.00
Mainz Biomed (MYNZ) Germany $0.007B 0.00
HCW Biologics (HCWB) United States $0.006B 0.00
Portage Biotech (PRTG) $0.006B 0.00
Arcadia Biosciences (RKDA) United States $0.006B 0.00
BRIACELL THERAP (BCTX) Canada $0.005B 0.00
Pasithea Therapeutics (KTTA) United States $0.005B 0.00
Polyrizon (PLRZ) Israel $0.005B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
VivoSim Labs (VIVS) United States $0.005B 0.00
Galecto (GLTO) Denmark $0.005B 0.00
Adial Pharmaceuticals (ADIL) United States $0.005B 0.00
GRI Bio (GRI) United States $0.005B 0.00
Revelation Biosciences (REVB) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Soligenix (SNGX) United States $0.004B 0.00
CNS Pharmaceuticals (CNSP) United States $0.004B 0.00
Windtree Therapeutics (WINT) United States $0.004B 0.00
Dermata Therapeutics (DRMA) United States $0.004B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.004B 0.00
Titan Pharmaceuticals (TTNP) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Enveric Biosciences (ENVB) United States $0.003B 0.00
AquaBounty Technologies (AQB) United States $0.003B 0.00
Psyence Biomedical (PBM) Canada $0.003B 0.00
Silo Pharma (SILO) United States $0.003B 0.00
Alzamend Neuro (ALZN) United States $0.003B 0.00
Aptevo Therapeutics (APVO) United States $0.002B 0.00
Entero Therapeutics (ENTO) United States $0.002B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.002B 0.00
Atrinsic (PTIX) United States $0.002B 0.00
Onconetix (ONCO) United States $0.002B 0.00
Bone Biologics (BBLG) United States $0.002B 0.00
NuCana (NCNA) United Kingdom $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00
Cocrystal Pharma (COCP) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.000B 0.00
Galapagos (GLPG) Belgium $0.000B 0.00
LakeShore Biopharma (LSB) China $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pulmatrix (PULM) United States $0.000B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.000B 0.00
TFF Pharmaceuticals (TFFP) United States $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00